Validation of a Method of Screening for Sleep Disorders in Children With Cerebral Palsy, Using Connected Tools

NCT ID: NCT03915418

Last Updated: 2025-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-12

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cerebral palsy (CP) is the most common cause of child disability. Nearly 40% of PC children suffer from sleep disorders, which are not routinely screened. The neuro-cognitive, physical and environmental morbidity of sleep disorders should require their diagnosis and management. Limited access to the reference exam (polysomnography or PSG) delays the diagnosis and only allows screening of these disorders for a limited number of PC children. The hypothesis of our study is that connected technologies could optimize screening for sleep disorders in PC children by selecting children requiring PSG exploration and specific management.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Connected tools

1 night at home with connected tools only and 1 night at hospital with connected tools and PSG.

Group Type EXPERIMENTAL

Connected tools

Intervention Type PROCEDURE

At home, parents will record their child's sleep for 1night Then, on the date scheduled for the inclusion of the children and after the recording of the 1 night at home, the child will spend a night in a hospital environment to carry out the recording by polysomnography and tools connected simultaneously.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Connected tools

At home, parents will record their child's sleep for 1night Then, on the date scheduled for the inclusion of the children and after the recording of the 1 night at home, the child will spend a night in a hospital environment to carry out the recording by polysomnography and tools connected simultaneously.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Boy or girl between 6 and 15 years old
* Confirmed diagnosis of cerebral palsy
* GMFCS class\> 3
* Parents and child agreement

Exclusion Criteria

* Pharmacological treatment of sleep disorders
* Diurnal and / or nocturnal ventilatory support
* Difficulty understanding and / or participation
* Subjects under 6 and over 15
* Refusal to participate
* Not affiliated with and not a beneficiary of a health insurance plan
Minimum Eligible Age

6 Years

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Brest

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Juliette Ropars, MD

Role: PRINCIPAL_INVESTIGATOR

Brest University Hospital in France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Angers

Angers, , France

Site Status NOT_YET_RECRUITING

CHRU Brest

Brest, , France

Site Status RECRUITING

Fondation Ildys Ty-Yann

Brest, , France

Site Status NOT_YET_RECRUITING

ESEAN Nantes

Nantes, , France

Site Status NOT_YET_RECRUITING

AP-HP Hôpital Trousseau

Paris, , France

Site Status NOT_YET_RECRUITING

Kerpape

Ploemeur, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Juliette Ropars, MD

Role: CONTACT

02 98 22 33 89 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mickael Dinomais, Professor

Role: primary

Juliette Ropars, MD

Role: primary

Audrey Barzic, MD

Role: primary

Guy Letellier, MD

Role: primary

Guillaume Aubertin, MD

Role: primary

Véronique Bernier-François, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SOUTIEN-PC (29BRC18.0178)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.